BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, April 14, 2026
Home » Authors » David N. Leff

Articles by David N. Leff

Gene Therapy For Heart Failure Pulled 59 Hamsters Back From Brink Via Transcoronary System

Sep. 3, 2002
By David N. Leff

From the lab: Benign prostatic hyperplasia seen as two diseases, not one

Sep. 1, 2002
By David N. Leff

From the lab: Angiogenesis relieves clogged leg arteries

Sep. 1, 2002
By David N. Leff

TIGR Completes Sequencing Of Streptococcus agalactiae; Chiron Searches For Vaccine

Aug. 30, 2002
By David N. Leff

Military Getting What It Ordered: Resistance Resisting Antibiotic, Portable On-Site Spore Detector

Aug. 29, 2002
By David N. Leff

Herpes Infects Mouse Virus To Take On Complement Killers In Acute, Chronic, Latent Infection

Aug. 27, 2002
By David N. Leff

Australian Vaccinologists Argue Toxins, Yes; Antigens, No' Show Anti-Malarial Parasite Protection

Aug. 26, 2002
By David N. Leff

A Molecule Named DARPP-32 Is Powerful Performer In Caffeine's Little-Known Psychostimulation

Aug. 23, 2002
By David N. Leff

Bypassing Bypassing, Marrow Stem Cells Invoke Angiogenesis To Relieve Clogged Leg Arteries

Aug. 22, 2002
By David N. Leff

Two Twitching Muscle-Fiber Types Divide Skeletal Muscle Chores With Potential For Enhanced Endurance

Aug. 21, 2002
By David N. Leff
Previous 1 2 … 25 26 27 28 29 30 31 32 33 … 50 51 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 14, 2026
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • Cancer cell in the cross-hairs

    Selective CBL-B inhibitor with improved safety profile disclosed

    BioWorld Science
    CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing